Broadenbio Ltd., Co.
Clinical trials sponsored by Broadenbio Ltd., Co., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill shows promise for Hard-to-Treat cancers Results expected Dec 2026 (estimated)
- New drug BB102 takes on Hard-to-Treat liver cancer Results expected Jun 2027 (estimated)